Hoppa till innehåll
Hoppa till innehåll

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 29 oktober 2019. Database contains 224 unique substances/entries.
Filter the list
Date of intention:
Date of RMOA conclusion:
Latest update:

 
207-995-2
504-60-9
Netherlands
Other environmental toxicity
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
15/08/2017
Details
200-001-8
50-00-0
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
225-625-8
4979-32-2
Germany
Bioaccumulation
Exposure
Persistence
Widespread use
Under development
Under development
No suggestion yet
28/02/2019
Details
207-069-8
431-03-8
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
256-032-2
42978-66-5
Sweden
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
15/08/2017
Details
255-288-2
41272-40-6
Netherlands
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
15/12/2017
Details
223-861-6
4098-71-9
Sweden
Exposure
Mutagenic
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
09/02/2018
Details
223-861-6
4098-71-9
Germany
Carcinogenic
Exposure
Mutagenic
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
Restriction
10/10/2019
Details
254-551-9
39635-79-5
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Pending
On hold
No suggestion yet
10/10/2019
Details
223-445-4
3896-11-5
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
05/12/2014
Details
223-383-8
3864-99-1
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
206-803-4
376-06-7
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Restriction
07/03/2017
Details
206-801-3
375-95-1
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Restriction
07/03/2017
Details
253-242-6
36861-47-9
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
222-883-3
3648-18-8
Sweden
Toxic for reproduction
Under development
Under development
No suggestion yet
10/10/2019
Details
253-037-1
36437-37-3
Germany
Bioaccumulation
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
222-583-2
3542-36-7
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
206-400-3
335-76-2
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Restriction
25/01/2019
Details
221-967-7
3296-90-0
Norway
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
SVHC
03/07/2018
Details
250-863-4
31906-04-4
Sweden
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
05/06/2015
Details
221-641-4
3173-72-6
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
10/10/2019
Details
221-573-5
3147-75-9
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details
206-203-2
307-55-1
Germany
Bioaccumulation
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
07/03/2017
Details
206-196-6
307-24-4
Germany
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Restriction
05/01/2018
Details
220-474-4
2778-42-9
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
220-239-6
2682-20-4
Denmark
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
04/05/2015
Details
247-722-4
26471-62-5
Denmark
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
247-714-0
26447-40-5
Denmark
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
247-421-8
26038-87-9
France
Endocrine disruption
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
23/09/2014
Details
219-799-4
2536-05-2
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
219-799-4
2536-05-2
Denmark
Carcinogenic
Mutagenic
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
246-563-8
25013-16-5
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Restriction
17/01/2019
Details
219-470-5
2440-22-4
Germany
Other human toxicity
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
05/12/2014
Details
219-154-7
2374-14-3
Netherlands
Bioaccumulation
Other human toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
CLH
10/07/2015
Details
245-152-0
22673-19-4
Sweden
Toxic for reproduction
Under development
Under development
No suggestion yet
25/10/2018
Details
205-923-4
218-01-9
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
244-168-5
21041-95-2
Sweden
Carcinogenic
Mutagenic
STOT RE
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
09/06/2017
Details
205-916-6
207-08-9
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
205-912-4
206-44-0
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
218-165-4
2058-94-8
Germany
Bioaccumulation
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
07/03/2017
Details
205-883-8
191-24-2
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
217-533-1
1879-09-0
France
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Under development
Under development
No suggestion yet
07/03/2017
Details
242-555-3
18755-43-6
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Pending
On hold
No suggestion yet
24/09/2019
Details
242-522-3
18718-11-1
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
242-060-2
18172-67-3
Greece
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/07/2017
Details
240-841-2
16812-54-7
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
12/05/2017
Details
240-260-4
16096-31-4
Denmark
Persistence
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
205-861-8
156-62-7
ECHA
Other human toxicity
STOT RE
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
Restriction
12/03/2018
Details
239-622-4
15571-58-1
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
23/09/2014
Details
3-benzylidene camphor; 3-BC
239-139-9
15087-24-8
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
216-036-7
1478-61-1
Sweden
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
20/12/2018
Details
205-391-3
140-01-2
France
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
01/04/2016
Details
205-355-7
139-13-9
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
12/01/2017
Details
205-288-3
137-30-4
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
237-159-2
13674-87-8
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
237-158-7
13674-84-5
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
696-364-9
133779-11-0
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
215-607-8
1333-82-0
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
03/05/2019
Details
215-271-2
1317-40-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
08/10/2015
Details
236-068-5
13138-45-9
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
215-204-7
1313-27-5
Denmark
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
19/12/2016
Details
215-185-5
1310-73-2
Sweden
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
Other
08/04/2015
Details
215-181-3
1310-58-3
Sweden
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
Other
08/04/2015
Details
205-031-5
131-57-7
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
01/04/2015
Details
205-029-4
131-56-6
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
205-028-9
131-55-5
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
215-157-2
1308-06-1
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
09/06/2017
Details
235-921-9
13048-33-4
Sweden
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
SVHC
04/05/2015
Details
215-133-1
1304-56-9
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
204-927-3
129-00-0
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
204-881-4
128-37-0
France
Carcinogenic
Endocrine disruption
Exposure
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
17/01/2019
Details
204-826-4
127-19-5
Commission
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
26/10/2018
Details
235-715-9
12607-70-4
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
603-051-2
125304-04-3
Germany
Bioaccumulation
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
01/04/2015
Details
204-661-8
123-91-1
Germany
Bioaccumulation
Persistence
Under development
Under development
No suggestion yet
30/08/2019
Details
629-757-0
1224966-15-7
Netherlands
Other environmental toxicity
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
None
05/07/2017
Details
214-946-9
1222-05-5
France
Endocrine disruption
Under development
Under development
No suggestion yet
09/08/2019
Details
629-719-3
1219010-04-4
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
26/04/2019
Details
235-008-5
12054-48-7
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
234-829-6
12035-72-2
Hungary
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
12/05/2017
Details
234-541-0
12008-41-2
Sweden
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/01/2018
Details
404-360-3
119313-12-1
Austria
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2019
Details
204-260-8
118-56-9
France
Endocrine disruption
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
03/05/2019
Details
204-126-9
116-14-3
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/12/2018
Details
204-118-5
115-96-8
Denmark
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
204-112-2
115-86-6
France
Endocrine disruption
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
11/09/2019
Details
214-317-9
1120-71-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
06/02/2015
Details
203-856-5
111-30-8
Sweden
Respiratory sensitiser
Skin sensitiser
Under development
Under development
No suggestion yet
08/07/2019
Details
234-323-5
11099-02-8
France
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
02/02/2017
Details
234-277-6
11059-65-7
Sweden
Toxic for reproduction
Under development
Under development
No suggestion yet
10/07/2019
Details
203-772-9
110-49-6
Sweden
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
29/11/2018
Details
203-632-7
108-95-2
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
203-625-9
108-88-3
Denmark
Mutagenic
Toxic for reproduction
Widespread use
Concluded
No need to initiate further regulatory risk management action at this time
None
12/01/2017
Details
203-625-9
108-88-3
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
09/11/2017
Details
203-585-2
108-46-3
Finland
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/09/2019
Details
214-012-0
1072-63-5
Sweden
Toxic for reproduction
Under development
Under development
No suggestion yet
10/04/2018
Details
203-473-3
107-21-1
Netherlands
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
09/11/2017
Details
203-471-2
107-19-7
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
09/11/2017
Details
EDA
203-468-6
107-15-3
ECHA
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
13/10/2016
Details
203-466-5
107-13-1
Germany
Mutagenic
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
23/09/2014
Details

Export search results to:

Categories Display


Route: .live1